Prescription drugs advertisements discourage trust in physicians’ knowledge

The argument

In a time when anyone can easily look up any symptom, from a rash to a sniffle, and attempt to self-diagnose, prescription drug advertising lands in an environment already primed for it. Proponents of this position argue that the combination is incredibly harmful to the medical profession: an advertisement gives a patient the name of a product and an implied indication for it, so the patient arrives at the consultation having already reached a conclusion. The advertisement is not neutral information, since it is designed to sell, but it can function in the patient's mind as though it were medical advice. Regulation does not fully close the gap. While the FDA does regulate these advertisements, some medications have slipped through the cracks with false advertising, and each instance introduces an incredible amount of misinformation regarding the health and well-being of patients and what treatments may be needed for certain health conditions. Those decisions should be made between a patient and their healthcare professional, not prompted by a cutesy commercial. The regulatory failure matters more than its frequency suggests, because a patient has no way of telling which advertisements passed scrutiny and which did not. The problem is compounded outside regulated channels. Advertisements for prescription drugs and non-FDA approved drugs are commonly seen on social media and other media platforms, promoted by celebrities and influencers whose endorsements carry personal credibility rather than clinical authority. That is precisely how misinformation and the promotion of potentially harmful products travel furthest. The cumulative effect is a shift in whom patients believe. Patients exposed to advertisements for harmful products may believe the advertisements more than they believe physicians, and once that happens a doctor's advice competes with marketing on marketing's terms. The result is deep distrust in medical professionals, which is why, on this view, there should not be advertisements for prescription drugs.

Premises

Counter-arguments

Direct-to-consumer (DTC) advertising is strictly regulated by the FDA. There is no federal law against DTC advertising, and prescription drug advertisements offer a way to inform consumers of the variety of treatments available to them beyond what their healthcare provider might suggest. Physicians are not infallible, and the more informed a consumer is, the better they are able to advocate for themselves and their health.

Rejecting the premises

[Rejecting P1] The premise runs together three different things: FDA-regulated direct-to-consumer advertising for prescription medicines, false claims that occasionally escape enforcement, and influencer promotion of unapproved products — which is not prescription advertising at all and is already unlawful in most of the forms described. A case built on the third does not support banning the first. [Rejecting P2] It is, and advertising does not change that. A prescription medicine cannot be obtained without a clinician writing for it, so the decision stays where the premise wants it; what an advertisement can do is prompt a consultation. The evidence here runs in both directions — such visits do increase requests for branded drugs where cheaper equivalents exist, and they also surface undiagnosed conditions in patients who would not otherwise have presented. [Rejecting P3] The step is asserted and little supports it. Surveys do not show that patients exposed to drug advertising trust doctors less, and the trend the premise is really describing — patients arriving with their own information — long predates it and is driven by search engines and online communities. The opposing view holds that a better-informed patient advocates more effectively, and the premise gives no reason to prefer its own reading.